medline.ch Gastroenterologie Leber Leberzirrhose

	Demographic Inequalities in Mortality Due to Hepatocellular Cancer in Male Patients With Alcoholic Cirrhosis in the United States: A CDC WONDER Database Analysis. Cureus Khan F, Ahmad A, Ayyazuddin M, Awan AR, Arshad S, Nadeem MA. PMID: 41473632 [PubMed]
	The Effects of Flaxseed Consumption on Frailty and Sarcopenia in Patients With Liver Cirrhosis: An Open-Labeled Randomized Controlled Clinical Trial. Food Sci Nutr Pashayee-Khamene F, Hekmatdoost A, Haidari F, Anushiravani A, Hatami B, Sadeghi A, Ahmadi-Engali K, Helli B. PMID: 41473401 [PubMed]
	Interactions Between Sarcopenia, Physical Frailty and Resting Energy Expenditure in Cirrhosis and Portal Hypertension. Nutrients Jacob R, Craik J, Pudipeddi A, Park L, Aw G, Ngu NLY, Sundaram P, Vidot H, Valliani T, Gill M, Staudenmann D, Bowen D, Strasser SI, McCaughan GW, Liu K. PMID: 41470789 [PubMed - indexed for MEDLINE]
	Evaluation of Prognosis in Cirrhotic Patients with Esophageal Variceal Bleeding Using Non-Invasive Scores. Medicina (Kaunas) K, Sar, , Ölmez . PMID: 41470196 [PubMed - indexed for MEDLINE]
	Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells. Cell Biosci Pan X, Gao T, Wang B. PMID: 41469927 [PubMed - as supplied by publisher]
	Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with Cirrhosis. J Nucl Med Catalano OA, Bhan I, Asmundo L, Bradley WR, Fonderico M, Zhang ML, Mojtahed A, Anderson MA, Herold A, Hajati A, Pena-Trujillo V, Caravan PD, Harrington SG, Esfahani SA, Mahmood U, Elias N, Walsh EP, Pratt DS, Scherrer AB, Ellis H, Bethea ED, Sirlin C, Kambadakone AR, Ryan D, Lau-Min K. PMID: 41469151 [PubMed - as supplied by publisher]
	Correlation between serum bile acids with severity of liver cirrhosis: A case-control study. Bioinformation Doshi S, Sonawane P, Agrawal U, Munshi AA. PMID: 41466655 [PubMed]
	SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope? Life (Basel) Brusnic O, Onisor DM, Boicean A, Porr C, Sofonea FD, Anderco P, Ichim C. PMID: 41465728 [PubMed]
	Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice? Int J Mol Sci Seidita A, Buscemi C, Di Liberto D, Pistone M, Maestri S, Cavallo G, Cosenza S, Spagnuolo G, Giuliano A, Carlisi D, Pratelli G, Mandreucci F, Carroccio A. PMID: 41465213 [PubMed - indexed for MEDLINE]
	Malnutrition Is Associated with Increased Liver Stiffness in Type 2 Diabetes: The Mediating Role of Inflammation. Biomolecules Lo Buglio A, Bellanti F, Villani R, Capurso C, Magnati GP, Cioffi S, Tedesco G, Torsello CA, Vendemiale G, Serviddio G. PMID: 41463388 [PubMed - indexed for MEDLINE]
	Ultrasound and SWE-based transfer learning for predicting fibrotic NASH. Sci Rep Xia F, Wang K, Wang Y, Zhang C, Wang J. PMID: 41461741 [PubMed - indexed for MEDLINE]
	Unveiling the Burden of Steatotic Liver Disease: Mortality Risks by Subtype and Fibrosis Stage in a Nationwide Cohort. Liver Int Feng Q, Manousou P, Izzi-Engbeaya CN, Loomba R, Thursz M, Woodward M. PMID: 41460581 [PubMed - indexed for MEDLINE]
	Explainable machine learning for prognostic modeling of waitlist mortality in cirrhotic liver transplantation. Comput Struct Biotechnol J Halimi A, Houmani N, Garcia-Salicetti S, Kounis I, Coilly A, Vibert E. PMID: 41459586 [PubMed]
	Identification of serum MicroRNAs associated with hepatic immunoinflammatory injury in chronic hepatitis B: implications for non-invasive diagnosis. Front Immunol Han M, Xu J, Wu X, Hu Z, Hu X, Zhu X, Chen C, Xuan Q, Li Y, Zhu C, Zhu L, Yang X, Li J. PMID: 41459517 [PubMed - indexed for MEDLINE]
	Research progress on nutritional support for patients with liver cirrhosis complicated by upper gastrointestinal bleeding. Front Nutr Dong Y, Chen PY, You C, Li JD, Chen ST. PMID: 41459059 [PubMed]
	Serum asprosin level is significantly lower in patients with liver cirrhosis than in those with non-cirrhotic chronic liver diseases. Front Endocrinol (Lausanne) Wang S, Wang Y, Zhang S, Li T, Zhou X, Chen L. PMID: 41458540 [PubMed - indexed for MEDLINE]
	Clinical impact and disparities in mortality and antimicrobial resistance between Gram-negative and Gram-positive bacteria in cirrhotic abdominal infections: a meta-analysis. Front Med (Lausanne) Xie XQ, Shao JW. PMID: 41458492 [PubMed]
	Endoplasmic Reticulum-Targeting Natural Compounds: A Novel Frontier in Alleviating Liver Fibrosis. Drug Des Devel Ther Huang C, Hu W, Qi J, Su B, Yan H, Zhu YZ. PMID: 41458255 [PubMed - indexed for MEDLINE]
	Acute kidney injury after TIPS in decompensated cirrhosis patients: a retrospective cohort study. BMC Nephrol Jia M, Guo YD, Ye PP, Zhou XL, Luo Y. PMID: 41455909 [PubMed - as supplied by publisher]
	SGLT-2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 Diabetes. Liver Int Kim DH, Ko D, Chen VL, Porres JA, Elizondo Alatorre C, Nieto LM, Palacios Argueta P, Kröner PT, Lukens FJ, Kim D, Karagozian R, Bansal MB, Wijarnpreecha K. PMID: 41454700 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 37674

Seite 1 von 1884

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung